ViOptix is dedicated to creating cost-effective tools using innovative optical technologies to provide real-time clinical information about the structure and function of human systems. We are focused on contributing to improve patient care. Our mission is to lead the development and marketing of products based on Diffuse Optical Imaging and Spectroscopy that will provide superior clinical solutions to our customers and their patients. ViOptix has the goal of commercializing research in optical diffusion imaging and spectroscopy (ODIS), a technology that characterizes tissue by measuring the scattering and absorption of photons.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 01/11/08 | Series D | 12.2M | Canadian Medical Discoveries Fund, Channel Medical Partners, Lincoln Funds International, MDS Capital, Morningside Group, Trident Investment, Vivo Ventures | Unknown |
People
Denise Yarmlak (Sr. Director of Marketing)
Jim Kirchberg (VP Sales)
Philipp Lang (Board Member)
Melissa Liu (Controller)
Timothy Lippert (VP Sales)
Competitors
Ometric:
Ometric Corporation provides innovative solutions to embed analytical technology into industrial processes. Ometric's SpectrInline Processware® utilizes… See Company Profile »
News
ViOptix finds $3M to measure oxygen levels in human tissue
January 25, 2010 6:34 pm
July 9-10, 2013 San Francisco, CA Tickets On Sale Now ViOptix, maker of a device that measures tissue oxygen levels… Continue reading ⟩
ViOptix spies $895K to measure tissue oxygen
October 26, 2009 4:52 pm
July 9-10, 2013 San Francisco, CA Tickets On Sale Now ViOptix, maker of a device that measures tissue oxygen levels… Continue reading ⟩
ViOptix snags $7.4M to measure tissue oxygen
December 5, 2008 7:46 pm
July 9-10, 2013 San Francisco, CA Tickets On Sale Now Biotech firm ViOptix just tacked $4.4 million onto an already… Continue reading ⟩